RecallDepth
Class II Terminated

Marcaine 0.5% (bupivacaine HCl) injection, USP, 250 mg/50 mL (5 mg/mL), 50 mL Multiple-Dose Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1610-50.

Company
Hospira Inc., A Pfizer Company
Recall Initiated
September 16, 2016
Posted
October 19, 2016
Recall Number
D-0097-2017
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
4768 vials
Firm Location
Lake Forest, IL, United States

Reason for Recall

Lack of Assurance of Sterility and Subpotent Drug: defect in glass vial prevented stopper from forming a seal allowing water to ingress and dilute the product causing it to be less than the labeled potency.

Distribution

Nationwide and Puerto Rico

Lot / Code Info

Lot #: 59310DD, Exp 1NOV2017

More recalls by Hospira Inc., A Pfizer Company

View all recalls by this company →

Other recent Class II Drug recalls